{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-114000","form_type":"8-K","ticker":"XRN","cik":"0001533615","company_name":"Chiron Real Estate Inc.","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.052420+00:00","generated_at":"2026-06-22T13:42:58.317118+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Global Medical REIT Q3 net income $8.1M, AFFO $0.25/share; adds $150M term loan, 80% fixed-rate debt","bullets":["Net income $8.1M ($0.12 diluted EPS) vs $3.7M ($0.06) prior year; revenue $35.4M, up 18.1% YoY","FFO $16.2M ($0.23/sh/unit) flat; AFFO $17.1M ($0.25) up from $0.24 prior year","Acquired $50.8M in Q3 (247k sf at 7.1% cap); YTD $148.9M; sold one asset for $17.9M, $6.8M gain","Amended credit facility: $150M term loan added (Feb 2028), revolver extended to Aug 2026, switched to SOFR","Entered $150M interest rate swaps fixing SOFR at 2.54%; 80% of debt now fixed at 3.75% wtd avg rate"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-114000","json":"https://secwatch.observer/filing/0001104659-22-114000.json","markdown":"https://secwatch.observer/filing/0001104659-22-114000.md","text":"https://secwatch.observer/filing/0001104659-22-114000.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/tm2229564d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T13:42:58.317118+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"afb46d8a994e120a9d638d2fc07fe07dee553bf8","claim":"Chiron Real Estate Inc. reported three months ended September 30, 2022 results: revenue $35.4 million, net income $8.1 million, EPS $0.12 per diluted share.","evidence_excerpt":"Net income attributable to common stockholders was $8.1 million, or $0.12 per diluted share, as compared to $3.7 million, or $0.06 per diluted share, in the comparable prior year period. · Funds from Operations (“FFO”) of $16.2 million, or $0.23 per share and unit, as compared to $15.8 million, or $0.23 per share and unit, in the comparable prior year period. · Adjusted Funds from Operations (“AFFO”) of $17.1 million, or $0.25 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 18.1% year-over-year to $35.4 million, primarily driven by the Company’s acquisition activity.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended September 30, 2022"},{"label":"Revenue","value":"$35.4 million"},{"label":"Net income","value":"$8.1 million"},{"label":"EPS","value":"$0.12 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"fcc8af40e24048e53a8f87f5a061fe70c69dbbb0","claim":"Chiron Real Estate Inc. reported nine months ended September 30, 2022 results: revenue $101.0 million, net income $13.0 million, EPS $0.20 per diluted share.","evidence_excerpt":"Net income attributable to common stockholders was $13.0 million, or $0.20 per diluted share, as compared to $8.0 million, or $0.13 per diluted share, in the comparable prior year period. · FFO of $48.6 million, or $0.70 per share and unit, as compared to $42.6 million, or $0.67 per share and unit, in the comparable prior year period. · AFFO of $51.5 million, or $0.74 per share and unit, as compared to $45.0 million, or $0.71 per share and unit, in the comparable prior year period. · Increased total revenue 18.0% year-over-year to $101.0 million, primarily driven by the Company’s acquisition activity.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2022"},{"label":"Revenue","value":"$101.0 million"},{"label":"Net income","value":"$13.0 million"},{"label":"EPS","value":"$0.20 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}